Enrolling Women in HIV Vaccine Trials: Challenges and Solutions
Author Information
Author(s): Edward Mills, Stephanie Nixon, Sonal Singh, Sonam Dolma, Anjali Nayyar, Sushma Kapoor
Primary Institution: McMaster University
Hypothesis
The challenge of enrolling women into HIV vaccine trials must be overcome for trials to be ethical and valid.
Conclusion
To conduct valid HIV vaccine trials, it is essential to address the unique barriers women face in participating.
Supporting Evidence
- Women represent nearly half of the 40.3 million HIV infections worldwide.
- Barriers to women's participation in trials stem from lower social status and lack of decision-making rights.
- Community involvement is crucial for addressing the unique needs of women in trials.
Takeaway
Women need to be included in HIV vaccine trials, but there are many challenges that make it hard for them to participate.
Potential Biases
Potential biases may arise from cultural and societal pressures affecting women's participation.
Limitations
The study does not provide specific data on the sample size or statistical analysis.
Participant Demographics
Women, particularly in developing countries, aged 15-49 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website